Life sciences firms are under growing pressure to raise the quality and consistency of their regulatory data. Amplexor’s VP of strategy for life sciences Romuald Braun asks how this influencing the way organisations manage it - and what will be their best bet for exploiting the transformation for the benefit of their own businesses?
Across the life sciences industry there is a call to transform regulatory information management (RIM). While international authorities setting new and often onerous reporting requirements, simultaneously the companies themselves are grasping the strategically important role that product data can play could play in future, in terms of driving productivity, efficiency and competitive differentiation.